Skip to main content

Table 2 Patient variables by drug (first course of drug therapy)

From: Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit

  Phenobarbital (N = 37) Ursodiol (N = 31) p-value
Gestational Age at Birth (%)    0.7628
 22–28 weeks 38 45
 28–34 weeks 40 32
  > 34 weeks 22 23
Male (%) 57 71 0.2261
Race (%)    0.1439
 Caucasian 58 61
 African American 20 32
 Other 22 7
IUGR (%) 19 32 0.2058
On Restricted Lipids at start of drug therapy (%) 46 39 0.5479
Length of Drug Course a 17 (13,38) 17 (12,32) 0.4557
Dose (mg/kg/day) a 4.48 (3.84, 5.05) 27.43 (22.39,29.00) n/a
Direct Bilirubin at start of drug therapy    0.8458
mg/dLb 7.1 (3.98) 6.9 (4.92)
umol/L b 121.1 (68.1) 118.0 (84.2)
  1. a: Median (lower quartile, upper quartile); b: Mean (SD). IUGR = in utero growth restriction